NLRP3 and lung carcinoma: To evaluate the clinical relevance of NLRP3 inflammasome activation in radiation-induced lung injury (RILI), we analyzed lung specimens obtained from four patients with locally advanced lung cancer who had undergone neoadjuvant concurrent chemoradiotherapy (CCRT) followed by surgery.